Candidiasis, Oral

28 registered clinical trials studyying Candidiasis, Oral.

Status	Trial	Sponsor	Phase
Unknown	CelAgace™ OraRinse Solution for Treatment of Candidiasis NCT03250923	CelaCare Technologies, Inc.	Phase 1 / Phase 2
Completed	Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis NCT06120816	Sanotize Research and Development corp.	Phase 1
Unknown	Effect of Oral Hygienization in Newborn on Candida Spp Colonization NCT04410250	Federal University of the Valleys of Jequitinhonha and Mucuri	N/A
Completed	Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Speci NCT03894839	Yuzuncu Yil University	N/A
Unknown	Relationship Between Oral Hygiene in Newborns and Candida Spp. NCT03873753	Faculty Sao Leopoldo Mandic Campinas	N/A
Completed	Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic NCT02818803	University of Sao Paulo	Phase 3
Completed	Novel Rinse to Treat in Oral Candidiasis in Cancer Patients NCT00612963	Biomedical Development Corporation	—
Completed	Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg NCT00235053	Allergy & Asthma Medical Group & Research Center	Phase 4
Completed	Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis NCT00665639	Astellas Pharma Inc	Phase 3
Completed	Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis NCT00666185	Astellas Pharma Inc	Phase 3
Completed	A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Ca NCT00128323	Kamuzu University of Health Sciences	Phase 3
Completed	Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Orop NCT02184351	Boehringer Ingelheim	Phase 3
Completed	A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of O NCT00001812	National Cancer Institute (NCI)	Phase 3
Completed	Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients NCT00002446	Schering-Plough	Phase 3
Completed	The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adol NCT00001448	National Cancer Institute (NCI)	—
Completed	Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups NCT00004781	National Institute of Dental and Craniofacial Research (NIDCR)	—
Completed	A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related NCT00002293	Bristol-Myers Squibb	N/A
Completed	A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have NCT00001065	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Orophary NCT00002133	Janssen, LP	N/A
Completed	A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infecti NCT00002282	Pfizer	N/A
Completed	Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluc NCT00002394	Novartis	N/A
Terminated	Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole NCT00005920	Merck Sharp & Dohme LLC	Phase 2
Completed	Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC NCT00002057	Bristol-Myers Squibb	N/A
Completed	The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infect NCT00002431	Procter and Gamble	N/A
Completed	A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Succ NCT00002341	Janssen, LP	N/A
Completed	A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive NCT00002399	Schering-Plough	Phase 2
Completed	Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystati NCT00002112	Pfizer	N/A
Completed	A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patien NCT00000951	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 4